Panel: FDA needs more accelerated approvals

Share this article:
Panel: FDA needs more accelerated approvals
Panel: FDA needs more accelerated approvals

A White House scientific panel has recommended that FDA expand its accelerated approval program to a broader range of drugs.

The Report To The President On Propelling Innovation In Drug Discovery, Development, and Evaluation says that broader accelerated approvals will require the agency to “strengthen the enforcement of requirements that drug sponsors investigate drugs' risks and benefits in the post-approval phase, and to ensure that FDA responds effectively to this knowledge.”

The report's recommendations strive to “double the efficiency of drug development by decreasing clinical failure, clinical trial costs, time to market, and regulatory uncertainty.”

Allowing limited drug approvals is another option the report says FDA should explore for narrow indications. The report adds that FDA should work with academic researchers, patients, prescribers, drug sponsors, payors, and its Risk Communication Advisory Committee to develop and evaluate new tools and approaches for effectively communicating risks and benefits to patients and the public.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Predicting your pink slip

Predicting your pink slip

Any time a firm needs to save money, high-salaried executives are targets

Private View: New ways to engage with customers

Private View: New ways to engage with customers

These healthcare social media campaigns successfully use emotion, altruism and the human desire to "brand" oneself to get customers engaged.